Performance analysis of Traws Pharma (TRAW)
Annual Return
Over the past 3 years, TRAW has had an average annual return of -71.51%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, TRAW has had an average annual return of -66.06%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, TRAW has had an average annual return of -65.56%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Jan 2, 2001, TRAW has had an average annual return of -16.20%, underperforming the benchmark SPY, which returned +9.03% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -45.77% | -87.27% | -52.35% | +15.47% | -74.68% | -63.50% | +22.58% | -81.99% | -90.62% | -33.92% | -76.28% | -70.92% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| -71.34% | +11,479,900% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% |
| 2002 | 2001 | ||||||||||
| -90.00% | +0% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +86.57% | -21.87% | +10.92% | -21.85% | +2.36% | -42.31% | -27.33% | -45.77% | |||||
| 2025 | -18.05% | -54.56% | -30.44% | -36.92% | -2.33% | +4.37% | +4.18% | -9.12% | +32.13% | +38.91% | +5.03% | -58.13% | -87.27% |
| 2024 | -8.66% | +15.86% | +28% | -34.66% | -13.02% | -22.19% | -11.34% | -6.42% | -36.55% | -14.26% | -9.15% | +93.98% | -52.35% |
| 2023 | +93.59% | -35.13% | -9.88% | +57.36% | +1.74% | +0.85% | -11.86% | -24.43% | -9.48% | -10.06% | +7.67% | +8.23% | +15.47% |
| 2022 | -23.52% | -16.93% | +13.58% | -24.46% | -15.12% | +11.88% | -8.76% | -0.78% | -26.27% | -18.28% | +15.97% | -22.66% | -74.68% |
| 2021 | +43.84% | +86.57% | -20.09% | -27.97% | -38.01% | +3.59% | -28.28% | +7.24% | -28.14% | -9.66% | -13.30% | -15.00% | -63.50% |
| 2020 | -10.52% | +26.47% | -30.23% | +3.34% | +35.48% | +35.71% | +101.76% | -79.07% | +16.33% | -7.15% | +11.54% | +60.62% | +22.58% |
| 2019 | +46.92% | +15.16% | -7.56% | +21.21% | -21.25% | -9.52% | -12.28% | -4.00% | -64.58% | -37.65% | -64.15% | +99.99% | -81.99% |
| 2018 | -8.67% | -20.44% | -22.94% | -55.95% | +5.41% | +2.56% | +13% | -4.87% | +13.80% | -28.34% | -17.49% | -51.38% | -90.62% |
| 2017 | +18.06% | +2.61% | +10.55% | -27.89% | -15.61% | +16.76% | -10.19% | -16.49% | +5.56% | +16.96% | -24.50% | -0.66% | -33.92% |
Drawdown analysis of Traws Pharma (TRAW)
The maximum drawdown for the TRAW was -100.00%, occurring on Jul 20, 2026. This drawdown has not yet recovered.
The current TRAW drawdown is -100.00%.
Since Jan 2, 2001 TRAW has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100.00% | Aug 9, 2013 | 3253 | Jul 20, 2026 | Ongoing | Ongoing | Ongoing |
| -90.00% | Jan 2, 2001 | 348 | May 28, 2002 | 2810 | Jul 25, 2013 | 3158 |
| -4.97% | Aug 5, 2013 | 1 | Aug 6, 2013 | 3 | Aug 9, 2013 | 4 |
| -0.32% | Jul 30, 2013 | 1 | Jul 31, 2013 | 2 | Aug 2, 2013 | 3 |